Institutet för Hälso- och
Sjukvårdsekonomi
Box 2127
SE-220 02 Lund
Besök: Råbygatan 2
Tel: 046-32 91 00
ihe[at]ihe.se
2017



Gudnadottir G, Ragnarson Tennvall G, Stalfors J & Hellgren J
Indirect costs related to caregivers’ absence from work after paediatric tonsil surgery
European Archives of Oto-Rhino-Laryngology 2017
Open Access


Jarl J, Nilsson P, Gerdtham U-G, Grahn B & Nyberg A
Hälsoekonomisk utvärdering av rehabiliteringsgarantin i Region Skåne – en retrospektiv registerstudie
IHE Rapport 2017:3, IHE: Lund, Sverige

Willis M, Johansen P, Nilsson A and Asseburg C
Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)
PharmacoEconomics 2017; 35(3): 375-96
Publicerad online: 12 november 2016 


Gralén K, Andersson E & Steen Carlsson K
Bemanning inom onkologiklinikerna i Sverige - en enkätstudie för Cancerfonden
Lund: IHE Rapport 2017:2

Ragnarson Tennvall G & Fasth A
Cord blood transplantation, a cost-effective alternative: a health-economic analysis of the National Swedish Cord Blood Bank
Bone Marrow Transplantation, 2017 Apr; 52 (4): 638-640

Norlin JM, Calara PS, Persson U & Schmitt-Egenolf M
Real-world outcomes in 2,646 psoriasis patients: One in five has PASI ≥ 10 and/or DLQI ≥ 10 under ongoing systemic therapy
Journal of Dermatological Treatment, 2017. E-publication ahead of print.

Willis M, Asseburg C, Nilsson A, Johnsson K & Kartman B
Multivariate Prediction Equations for HbA1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modelling
Value in Health, 2017 Mar; 20 (3): 357-371
Published online: December 2016


Calara PS, Althin R, Steen Carlsson K & Schmitt-Egenolf M
Regional Differences in the Prescription of Biologics for Psoriasis in Sweden: A Register-Based Study of 4168 Patients
BioDrugs, 2017; 31(1): 75-82
Online First Articles, 17 January 2017


Moen F, Svensson J & Steen Carlsson K
Assessing the value of cancer treatments from real world data—Issues, empirical examples and lessons learnt
Journal of Cancer Policy 2017; 11: 32–37

Lindgren P, Jönsson & Wilking N
Assessment of value for resource allocation in cancer care
Journal of Cancer Policy 2017 11: 12-18

Ericsson Å & Lundqvist A
Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden
Applied Health Economics and Health Policy, 2017; 15: 237-248
Online First Articles, 06 January 2017

© IHE 2017